Interleukin-31: The Inflammatory Cytokine Connecting Pruritus and Cancer
Frontiers in Bioscience-Landmark · 2024
DOI: 10.31083/j.fbl2909312 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience-Landmark, 2024. Verfasst von Sabah Akhtar und 8 weiteren Autor:innen. Beteiligte Einrichtung: Translational Research Institute, Academic Health System, Hamad Medical Corporation, 3050 Doha, Qatar. Hauptthemen laut MEDLINE: Pruritus, Neoplasms, Interleukins. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Interleukin 31 (IL-31) is a proinflammatory cytokine, mainly secreted by Type II helper T cells. It signals through a heterodimeric receptor complex composed of IL-31 receptor α and oncostatin-M receptor β chain. The hallmark feature of IL-31, in its pathological role, is its ability to induce pruritus in mammals. Pruritus is a common symptom and major reason of morbidity in cancer patients, compromising their quality of life. Although, IL-31 is differentially expressed in different tumor types and could promote or inhibit cancer progression, high expression of IL-31 is a contributing factor to advanced stage tumor and severity of pruritus. The simultaneous existence of pruritus and cancer could either result from the aberrations in common proteins that co-exist in both cancer and pruritus or the therapeutic treatment of cancer could indirectly induce pruritus. Although the biology of IL-31 has predominantly been described in skin diseases such as atopic dermatitis and other inflammatory diseases, the precise role of IL-31 in the tumor biology of different cancer types remains elusive. Herein, we summarize the current understanding on the role of this cytokine in the pathogenesis of different cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Research Institute, Academic Health System, Hamad Medical Corporation, 3050 Doha, Qatar.
- Dermatology Institute, Academic Health System, Hamad Medical Corporation, 3050 Doha, Qatar.
- Department of Dermatology and Venereology, Hamad Medical Corporation, 3050 Doha, Qatar.
- Institute of Transplantation Diagnostics and Cell Therapeutics, University Hospital Dusseldorf, 40225 Dusseldorf, Germany.
Zitieren
APA
Akhtar, S., Ahmad, F., Alam, M., Ansari, A. W., Uddin, S., Steinhoff, M., Buddenkotte, J., Ahmad, A., & Datsi, A. (2024). Interleukin-31: The Inflammatory Cytokine Connecting Pruritus and Cancer. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/j.fbl2909312
Vancouver
Akhtar S, Ahmad F, Alam M, Ansari AW, Uddin S, Steinhoff M, et al. Interleukin-31: The Inflammatory Cytokine Connecting Pruritus and Cancer. Frontiers in Bioscience-Landmark. 2024. doi:10.31083/j.fbl2909312
BibTeX
@article{Akhtar2024,
author = {Akhtar, Sabah and Ahmad, Fareed and Alam, Majid and Ansari, Abdul Wahid and Uddin, Shahab and Steinhoff, Martin and Buddenkotte, Joerg and Ahmad, Aamir and Datsi, Angeliki},
title = {Interleukin-31: The Inflammatory Cytokine Connecting Pruritus and Cancer},
journal = {Frontiers in Bioscience-Landmark},
year = {2024},
doi = {10.31083/j.fbl2909312}
}
EUVIMED